Login
MediPharm Labs OTC Market: MEDIF
MediPharm Labs Corp. produces and sells pharma-grade cannabis oil and concentrates for derivative products in Canada and Australia
| Name | MediPharm Labs |
| Ticker | MEDIF |
| Exchange | OTC Market |
| Sector | Health Care |
| Industry | Cannabis Processor |
|
Price
52W Low/High |
0.38
0.37 / 1.59 |
| Momentum | Weak Down |
| Market cap | - |
| 1Y Total Return |
-78.24%
Weak |
| 1Y Volatility |
100.64%
High Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
MediPharm Labs Corp. produces and sells pharma-grade cannabis oil and concentrates for derivative products in Canada and Australia
Details
| Ticker | MEDIF |
| Name | MediPharm Labs |
| ISIN | CA58504D1006 |
| CUSIP | |
| Exchange | OTC Market |
| Sector | Health Care |
| Industry | Cannabis Processor |
| Country | Canada |
| Currency | U.S. Dollar |
Share as of 3/5/21
| Close Price | 0.38 |
| 52W Low/High | 0.37 / 1.59 |
| Market cap | - |
| 1Y Total Return |
-78.24%
Weak |
| 1Y Volatility |
100.64%
High Risk |
| Beta | -0.07 |
| PE (trailing) | - |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | - |
| Cash from Op. / Cur. Liabilities | - |
| Diluted Earnings / Share | - |
| ROE | - |
| ROIC | - |
| Price / Revenue | - |
| Price / Book | - |
| Price / CF | - |
| Current Ratio | - |
| Cur.Liabilities / Tot.Liabilities | - |
| Financial Leverage | - |
No quarterly accounting data available at the moment
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available